Prenatal Exposures Are Associated With Worse Neurodevelopmental Outcomes in Infants With Neonatal Opioid Withdrawal Syndrome

Aim: To define a developmental trajectory in infants with neonatal opioid withdrawal syndrome (NOWS) and determine whether the impacted developmental domain varies with the type of antenatal exposure.Methods: We performed a retrospective cohort study of infants treated pharmacologically for NOWS and...

Full description

Saved in:
Bibliographic Details
Main Authors: Kristen L. Benninger (Author), Teresa Borghese (Author), Jason B. Kovalcik (Author), Melissa Moore-Clingenpeel (Author), Cherie Isler (Author), Elizabeth M. Bonachea (Author), Ann R. Stark (Author), Stephen W. Patrick (Author), Nathalie L. Maitre (Author)
Format: Book
Published: Frontiers Media S.A., 2020-08-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_d73b93f2ecd9479ea73265e6d8413782
042 |a dc 
100 1 0 |a Kristen L. Benninger  |e author 
700 1 0 |a Kristen L. Benninger  |e author 
700 1 0 |a Teresa Borghese  |e author 
700 1 0 |a Jason B. Kovalcik  |e author 
700 1 0 |a Melissa Moore-Clingenpeel  |e author 
700 1 0 |a Cherie Isler  |e author 
700 1 0 |a Elizabeth M. Bonachea  |e author 
700 1 0 |a Ann R. Stark  |e author 
700 1 0 |a Stephen W. Patrick  |e author 
700 1 0 |a Nathalie L. Maitre  |e author 
700 1 0 |a Nathalie L. Maitre  |e author 
700 1 0 |a Nathalie L. Maitre  |e author 
245 0 0 |a Prenatal Exposures Are Associated With Worse Neurodevelopmental Outcomes in Infants With Neonatal Opioid Withdrawal Syndrome 
260 |b Frontiers Media S.A.,   |c 2020-08-01T00:00:00Z. 
500 |a 2296-2360 
500 |a 10.3389/fped.2020.00462 
520 |a Aim: To define a developmental trajectory in infants with neonatal opioid withdrawal syndrome (NOWS) and determine whether the impacted developmental domain varies with the type of antenatal exposure.Methods: We performed a retrospective cohort study of infants treated pharmacologically for NOWS and assessed using a standardized schedule for follow-up visits. We compared outcomes of the study population to published norms using one-sample t-tests. Multivariable models examined associations with exposures in addition to opioids.Results: In our cohort of 285 infants with 9-12-months testing, 164 (55.7%) were seen at 3-4 months, and 125 (44%), at 15-18 months. The majority (58%) had intrauterine drug exposures in addition to opioids. Neurodevelopmental scores of infants with NOWS at 3-4 and 9-12 months were not different from published norms. Cognitive and language scores at 15-18 months were worse than published norms. Male sex, older maternal age, and additional barbiturate or alcohol exposure were associated with worse outcomes.Conclusion: Infants with pharmacologically treated NOWS had development similar to unexposed infants during the 1st year but worse cognitive and language scores during the 2nd year. These data support the need for a prospective follow-up of large cohorts of infants with NOWS, with systematic assessments and an evaluation of contributing factors. 
546 |a EN 
690 |a in utero exposure 
690 |a neonatal abstinence syndrome 
690 |a neonatal opioid withdrawal syndrome 
690 |a neurodevelopment 
690 |a opioid 
690 |a Pediatrics 
690 |a RJ1-570 
655 7 |a article  |2 local 
786 0 |n Frontiers in Pediatrics, Vol 8 (2020) 
787 0 |n https://www.frontiersin.org/article/10.3389/fped.2020.00462/full 
787 0 |n https://doaj.org/toc/2296-2360 
856 4 1 |u https://doaj.org/article/d73b93f2ecd9479ea73265e6d8413782  |z Connect to this object online.